Health IT

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

A Canadian upstart is poised to unlock a massive, untreated market by moving glaucoma surgery from the OR to the office. This isn't just a new device; it's a strategic dismantling of a decades-old bottleneck.

With 80% of trials delayed, the life sciences industry is gathering to tackle its patient enrollment crisis. Can new partnerships and AI finally move the needle?

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

Metropolitan Dermatology is the first in NJ to adopt Nevisense®, an AI-backed scanner for melanoma. Is this tech a true game-changer or one move in a complex market?

As rural hospitals face financial collapse, a new wave of AI-powered technology is proving it can stabilize finances and preserve access to essential care.

TelyRx just filled its millionth prescription, but the real story isn't the number. It's the 'operational innovation' of its cash-pay model that's disrupting healthcare.

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

Phenomenex, a Danaher company, launches its Luna Omega HILIC columns, aiming to simplify complex analysis in pharma, food safety, and diagnostics.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

Beyond a simple plea for donations, Héma-Québec is executing a sophisticated strategic campaign to secure Quebec's most vital, and volatile, supply chain.

New trial data shows Sequel Med Tech's twiist™ AID system could bring much-needed simplicity and safety to millions with insulin-treated type 2 diabetes.

A landmark study validates Ceribell's AI in predicting neurological outcomes, signaling a major shift in critical care and bolstering its competitive edge.

A CPG veteran launches Lioness, a functional gummy snack for women. Can timed ingredients and a massive retail launch redefine the wellness market?

With its new SmartBioSurface slides, Italian firm Tethis aims to solve a major lab challenge. The key? A nanotech surface that could reshape disease research.

Portable oxygen offers freedom, but as companies market summer travel, a closer look reveals that not all devices may deliver on their life-sustaining promise.

Sleep is now a bankable asset. A new wave of research is changing how high-stakes industries like aviation manage fatigue, turning rest into a strategic advantage.